National Institute for Health and Care Excellence

NICE to approve icosapent ethyl for some high-risk cardiovascular patients

The National Institute for Health and Care Excellence says 425,000 people with established cardiovascular disease could benefit from treatment with icosapent ethyl.…

NICE has ‘failed to listen to patient evidence’ on prescription drug withdrawal, claims parliamentary group

The All-Party Parliamentary Group for Prescribed Drug Dependence has criticised the National Institute for Health and Care Excellence on its new guidance on tapered withdrawal of dependency-forming drugs.…

NICE recommends continuous glucose monitoring for all patients with type 1 diabetes 

Patients will now have a choice in picking the technology that is right for them based on their individual preferences and needs.…

NICE removes budesonide from recommended COVID-19 treatments

In updated guidance, the National Institute for Health and Care Excellence said there was “no statistically significant difference” between patients treated with inhaled budesonide for COVID-19 and those who received usual care.…

NICE draft guidance on medicines associated with dependence could be ‘harmful’, warns RPS

The Royal Pharmaceutical Society's response to a consultation says guidance on “slow tapering” is “open to too much interpretation”.…

Injectable treatment recommended by NICE for patients with high cholesterol

The cholesterol-lowering treatment inclisiran could be a "game-changer" in preventing heart attacks and strokes, says the National Institute for Health and Care Excellence.…

NICE approves first treatment through fast-tracked appraisal pilot

Bimekizumab, which is used for the treatment of severe plaque psoriasis, is the first treatment to be approved by a National Institute for Health and Care Excellence sub-committee in a trial fast-track appraisal process.…

Gillian Leng: ‘COVID-19 has been a strain, but also an opportunity’

The National Institute for Health and Care Excellence’s new chief executive, Gillian Leng, took the helm in April 2020. She speaks to us about what lessons the organisation has taken away from the past year.…

First antimicrobial drugs purchased via new ‘subscription’ payment model

The first antimicrobial drugs have been purchased via the UK’s new ‘subscription-type’ payment model.…

Not enough evidence for use of vitamin D in prevention or treatment of COVID-19, NICE rapid guidance concludes

There is not enough evidence to support taking vitamin D solely to prevent or treat COVID-19, according to rapid guidance published by the National Institute for Health and Care Excellence.…